Reviva Pharmaceuticals Holdings, Inc.
NASDAQ:RVPH
Income Statement
Earnings Waterfall
Reviva Pharmaceuticals Holdings, Inc.
Income Statement
Reviva Pharmaceuticals Holdings, Inc.
| Feb-2019 | May-2019 | Aug-2019 | Nov-2019 | Feb-2020 | May-2020 | Aug-2020 | Nov-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||||||||||
| Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(5)
|
(6)
|
(10)
|
(16)
|
(19)
|
(20)
|
(28)
|
(28)
|
(34)
|
(42)
|
(40)
|
(41)
|
(38)
|
(35)
|
(31)
|
(29)
|
(27)
|
(23)
|
|
| Selling, General & Administrative |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(3)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(7)
|
(8)
|
(8)
|
(9)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(2)
|
(5)
|
(10)
|
(14)
|
(15)
|
(23)
|
(23)
|
(26)
|
(34)
|
(31)
|
(32)
|
(29)
|
(27)
|
(23)
|
(21)
|
(19)
|
(15)
|
|
| Other Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(0)
N/A
|
(0)
-38%
|
(0)
-44%
|
(0)
-29%
|
(1)
-86%
|
(1)
-27%
|
(1)
-47%
|
(2)
-14%
|
(3)
-96%
|
(5)
-51%
|
(6)
-43%
|
(10)
-56%
|
(16)
-55%
|
(19)
-24%
|
(20)
-6%
|
(28)
-38%
|
(28)
+2%
|
(34)
-21%
|
(42)
-24%
|
(40)
+5%
|
(41)
-3%
|
(38)
+8%
|
(35)
+8%
|
(31)
+11%
|
(29)
+4%
|
(27)
+7%
|
(23)
+16%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||
| Interest Income Expense |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
0
|
1
|
1
|
1
|
0
|
0
|
(0)
|
|
| Pre-Tax Income |
1
N/A
|
1
+61%
|
1
+28%
|
1
-11%
|
1
-41%
|
0
-80%
|
(1)
N/A
|
(1)
-73%
|
(2)
-71%
|
(3)
-74%
|
(5)
-52%
|
(9)
-64%
|
(15)
-75%
|
(19)
-25%
|
(20)
-7%
|
(28)
-42%
|
(28)
+2%
|
(34)
-23%
|
(42)
-23%
|
(39)
+6%
|
(40)
-2%
|
(36)
+10%
|
(33)
+8%
|
(30)
+10%
|
(29)
+3%
|
(27)
+6%
|
(23)
+16%
|
|
| Net Income | ||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
1
|
1
|
1
|
1
|
1
|
0
|
(1)
|
(1)
|
(2)
|
(3)
|
(5)
|
(9)
|
(15)
|
(19)
|
(20)
|
(28)
|
(28)
|
(34)
|
(42)
|
(39)
|
(40)
|
(36)
|
(33)
|
(30)
|
(29)
|
(27)
|
(23)
|
|
| Net Income (Common) |
1
N/A
|
1
+61%
|
1
+28%
|
1
-11%
|
1
-41%
|
0
-80%
|
(1)
N/A
|
(1)
-73%
|
(2)
-71%
|
(3)
-74%
|
(5)
-52%
|
(9)
-64%
|
(15)
-75%
|
(19)
-25%
|
(20)
-7%
|
(28)
-42%
|
(28)
+2%
|
(34)
-23%
|
(42)
-23%
|
(39)
+6%
|
(40)
-2%
|
(36)
+10%
|
(33)
+8%
|
(30)
+10%
|
(29)
+3%
|
(27)
+6%
|
(23)
+16%
|
|
| EPS (Diluted) |
0.28
N/A
|
0.36
+29%
|
0.46
+28%
|
0.41
-11%
|
0.24
-41%
|
0.05
-79%
|
-0.25
N/A
|
-0.42
-68%
|
-0.16
+62%
|
-0.26
-63%
|
-0.28
-8%
|
-0.58
-107%
|
-0.98
-69%
|
-1.23
-26%
|
-0.76
+38%
|
-1.45
-91%
|
-1.27
+12%
|
-1.52
-20%
|
-1.77
-16%
|
-1.65
+7%
|
-1.34
+19%
|
-1.19
+11%
|
-0.98
+18%
|
-0.9
+8%
|
-0.59
+34%
|
-0.54
+8%
|
-0.31
+43%
|
|